Alagene
Alagene is an Israel-based synthetic biology CRO providing end-to-end DBTL (Design-Build-Test-Learn) services — computational design, precision fermentation, high-throughput screening, and downstream analytics — to pharma, food tech, cosmetics, clean tech, agtech, and academic clients worldwide.
- Company typePrivate
- Founded2021
- HeadquartersRehovot, Israel
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Alagene does
Alagene is an Israeli biotechnology Contract Research Organization (CRO) founded in 2021 and headquartered in Rehovot, providing end-to-end synthetic biology services across the full DBTL (Design-Build-Test-Learn) lifecycle. The company delivers four core technical capabilities: Computational Design & Cell Engineering for designing and engineering fungi, bacteria, and yeast cells; Precision Fermentation & Process Design spanning lab-scale to commercial production; High-Throughput Screening (HTS) and Bio-Assay Development capable of screening up to 1,000 colonies per day; and Downstream Process & Analytics including chromatography-based purification. Alagene operates proprietary technology assets including a Mini Multi-Chamber Fermentation System that achieves over 100-fold yield improvements and proprietary high-throughput assays for yeast and bacterial strain optimization, supported by ISO 9001:2015 certified quality management.
Alagene's revenue model is professional services / fee-for-service, with project-based pricing dependent on scope, complexity, and timeline, and multi-year contracts available. Revenue streams comprise core Contract Research Services plus Consulting Services spanning product development, R&D strategy, business strategy, IP management, technology transfer, and regulatory compliance. The go-to-market motion is enterprise field sales combined with event-driven and community-led channels: direct business development, conference participation (BioMed Israel, Israeli Fermentation Society, PLANETTech World, Scojen, Cultivated Meat Consortium), and academic community engagement via iGEM sponsorship and Tel Aviv University collaboration.
The company serves six customer segments: Pharma & Biotechnology (drug discovery, protein expression/purification), FoodTech & Food Industry (cultured meat growth factors, food preservation), Cosmetics & Personal Care (bacterial strains for novel ingredients), CleanTech & Industrial Biotechnology (carbon utilization), AgTech & Agriculture (scalable downstream processes), and Academic & Research Institutions. Named customers include startup Isfar Bio Group, enterprise R&D Science & Lab Solutions, and Prof. Tamir Tuller's lab at Tel Aviv University. The team is led by CEO Dr. Orly Savion, VP R&D Dr. Neta Agmon, and Chairman Dotan Buchsweiler (CEO of Hylabs), with senior quality/regulatory consulting from Ilanit Burnstein.
Alagene firmographics
Firmographics- Name
- Alagene
- Website
- https://alagene.co.il
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Alagene is an Israel-based synthetic biology CRO providing end-to-end DBTL (Design-Build-Test-Learn) services — computational design, precision fermentation, high-throughput screening, and downstream analytics — to pharma, food tech, cosmetics, clean tech, agtech, and academic clients worldwide.
- Ownership category
- akta.pro rank
Alagene industry classification
Industry- Product category
- Contract Research Organization (Biotechnology CRO Services)
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
Keywords
Where Alagene is headquartered
LocationHeadquarters
- HQ city
- Rehovot
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
Alagene business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Contract Research Services (CRO): Alagene provides fee-for-service biotechnology research and development services on a project basis. Clients engage Alagene for specific stages of the biotechnology development lifecycle, from R&D through commercialization. Services are billed per project with pricing based on scope, complexity, and timeline requirements.
- Consulting Services: Expert consulting in product development, R&D strategy, business strategy, IP management, technology transfer, and regulatory compliance. These services complement core R&D offerings and provide additional revenue streams.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels7 records
Alagene product offering
Product offeringCore offering
Alagene is a biotechnology Contract Research Organization (CRO) providing end-to-end synthetic biology solutions across the Design-Build-Test-Learn (DBTL) lifecycle, from R&D through commercialization. Its modular service offering spans computational design and cell engineering, high-throughput screening and bio-assay development, precision fermentation process design, and downstream processing and analytics, complemented by R&D and business strategy consulting. Services are delivered on a custom project basis to pharmaceutical, biotech, food tech, cosmetics, CleanTech, agtech, and academic clients.
Product overview
Alagene is a biotechnology CRO (Contract Research Organization) providing end-to-end solutions across the synthetic biology lifecycle from Design, Build, Test, to Learn (DBTL). Their modular service model offers six core services: Computational Design & Cell Engineering for designing and engineering microorganisms; HTP Screening & Bio-Assay Development for high-throughput strain screening; Precision Fermentation Process Design for scalable production; Downstream Process & Analytics for purification and analysis; Product and R&D Consulting for development guidance; and Business Strategy Consulting for IP and regulatory matters. The company serves diverse sectors including pharma, biotech, food tech, CleanTech, cosmetics, and agtech.
Differentiator
Problem solved
Functional benefit
Products and services
- Computational Design & Cell Engineering
Quantifiable outcome
- Reduced cultured meat growth factor production costs by 1000-fold through yeast and bacterial expression systems
- +3 more outcomes
Companies that use Alagene
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles5 records
Alagene technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Alagene partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- The Cultivated Meat ConsortiumcoreAlagene is a member of the Cultivated Meat Consortium, collaborating on developing yeast and bacterial systems that express growth factors at high yields for the cultured meat industry, achieving potential 1000-fold cost reduction.
- Prof. Tuller Lab (Tel Aviv University)coreCollaborative research partnership with Professor Tamir Tuller at Tel Aviv University focusing on growth factor expression for cultivated meat. This partnership combines academic computational expertise with Alagene's industrial capabilities.
- Modern Agriculture Foundation (MAF)minorAlagene signed the Commitment to Gender Equality at MAF's AgFood 2025 annual conference, demonstrating commitment to DEI principles in the agriculture and food tech sector.
- iGEM (International Genetically Engineered Machine)minorAlagene supports iGEM competition as a sponsor, building relationships with emerging talent and the synthetic biology academic community.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Alagene competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: Global contract laboratory services group spanning life sciences, food, and pharma testing. Comparable to Alagene as a broad-spectrum CRO serving overlapping end markets, though focused on testing rather than strain engineering.
- GenScript: Global biotech services company offering gene synthesis, protein production, and CRO services. Comparable to Alagene in protein expression/purification and synbio services for pharma and academic clients.
- Novonesis (formerly Novozymes): Global industrial biotechnology leader in enzymes and microbial solutions for food, agriculture, and pharma. Overlaps with Alagene's industrial biotech and fermentation services, but at much larger scale and broader product portfolio.
Direct peers
- Codexis: Specialist in enzyme engineering and biocatalysis serving pharma and industrial biotech customers. Comparable to Alagene in the protein/strain engineering and process optimization value chain, with overlapping customers and use cases.
- Conagen: Synthetic biology CRO focused on strain engineering, fermentation, and bioproduction for food, beauty, and pharma customers. Closest direct analog to Alagene's DBTL services model and target verticals.
- Ginkgo Bioworks: US-listed synthetic biology platform providing cell engineering and fermentation services to enterprise clients across food, pharma, and industrial biotech. Most directly comparable to Alagene in offering end-to-end synbio R&D services, though at vastly greater scale.
- Culture Biosciences: Cloud fermentation CRO offering high-throughput strain screening and process development services to synbio startups. Closely mirrors Alagene's fermentation/HTS service layer.
- Twist Bioscience: Synthetic biology company offering DNA synthesis, antibody libraries, and biopharma services. Comparable to Alagene in serving synbio R&D customers, with overlap in life sciences tooling.
- Amyris: Synthetic biology company using yeast fermentation to produce ingredients for cosmetics, food, and clean tech. Overlap with Alagene's fermentation-for-cosmetics-and-food value proposition and customer base.
Emerging players
- Bota Bio: Synthetic biology company offering strain engineering and biomanufacturing services for industrial applications. Comparable to Alagene in serving industrial biotech customers with fermentation-driven process development.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Alagene social profiles
Digital presenceAlagene compliance and trust
Trust signalCompliance1 record
Alagene financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alagene leadership team
Management profileNumber of profiles
Profiles4 records
Alagene funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alagene M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alagene
What does Alagene do?
Alagene is a biotechnology Contract Research Organization (CRO) providing end-to-end synthetic biology solutions across the Design-Build-Test-Learn (DBTL) lifecycle, from R&D through commercialization. Its modular service offering spans computational design and cell engineering, high-throughput screening and bio-assay development, precision fermentation process design, and downstream processing and analytics, complemented by R&D and business strategy consulting. Services are delivered on a custom project basis to pharmaceutical, biotech, food tech, cosmetics, CleanTech, agtech, and academic clients.
Is Alagene a public or private company?
Alagene is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Alagene founded?
Alagene was founded in 2021. It employs 11 to 50 people.
Where is Alagene based?
Alagene is headquartered in Rehovot, Israel, in the Middle East region.
How does Alagene make money?
Two revenue lines are on record. Contract Research Services (CRO) is the primary driver. The others are consulting Services.
Who are Alagene's main competitors?
Broad incumbents on record are Eurofins Scientific, GenScript and Novonesis (formerly Novozymes). Direct peers are Codexis, Conagen, Ginkgo Bioworks, Culture Biosciences, Twist Bioscience and Amyris. Bota Bio is listed as an emerging player.
Does Alagene have an API?
No public API is recorded for Alagene.
What industry is Alagene in?
Alagene's product category is Contract Research Organization (Biotechnology CRO Services). Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 541714 and its SIC code is 8731.